New peer-reviewed study shows significant real-world improvement in pressure-ulcer healing with advanced cellular, acellular, ...
TipRanks on MSN
BioStem Technologies’ Promising Clinical Trial for Venous Leg Ulcers: A Potential Game-Changer
BioStem Technologies (($BSEM)) announced an update on their ongoing clinical study. BioStem Technologies is conducting a clinical study titled A ...
AOTI, Inc. (($GB:AOTI)) announced an update on their ongoing clinical study. The clinical study titled A Multi-national, Prospective, Randomized, ...
A Florida mother is suing a Bradenton hospital for $100,000, claiming delayed care led to her leg being amputated due to misleading information that the hospital offered 24/7 emergency vascular ...
Leg pain is a common issue for women over 40. It can stem from arthritis, varicose veins, or vitamin deficiencies. Hormonal changes also play a role. Key symptoms include swelling and pain that ...
August 12, 2025—BioLab Holdings, Inc., recently announced the initiation of the BIOCAMP study assessing the company’s human placental membrane (HPM) products in the management of nonhealing diabetic ...
Venous leg ulcers (VLUs) account for 70% to 90% of all chronic leg ulcers, imposing a heavy burden on both patients and our health care system globally. High recurrence rates, slow healing, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results